Search results
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.
This test measures the beta-amyloid ratio (1-42/1-40) in cerebrospinal fluid. The beta-amyloid ratio (1-42/1-40) is a surrogate marker of amyloid plaque burden, caused by increased deposition of beta-amyloid 1-42 in the brain. Chemiluminescent Immunoassay/Calculation.
A systematic review and meta‐analysis was performed to determine (1) the effect of aerobic exercise on waist circumference in adults with overweight or obesity; (2) the association between any change in waist circumference and change in visceral adipose tissue and/or bodyweight with aerobic exercise interventions; and (3) if reductions in waist ...
The application includes modules for chart review, medication reconciliation, participant contact and biospecimen logging, survey recording, randomization, and documentation of genetic counseling and result disclosure. ... Awareness, Evaluation, and Treatment in Severe Dyslipidemia in US Adults. Mayo Clinic proceedings Shetty, N. S., Gaonkar, M ...
The trends over the past decade in each of the 7 cardiovascular health metrics (for diet, trends from 2003–2004 to 2011–2011) are shown in Chart 2-11 (for children 12–19 years of age) and Chart 2-12 (for adults ≥20 years of age).
We aimed to assess the utility of bispectral index (BIS) monitoring to diagnose brain death (BD) in patients with severe traumatic brain injury (TBI). A prospective observational study was conducted for patients with severe TBI between 2012 and 2014.
Study finds that the insulin-sensitiser pioglitazone, as a treatment for non-alcoholic fatty liver disease (NAFLD), shows some improvements in liver histology and other parameters
